TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08.05.2023 - MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) - TELA Bio, Inc. ('TELA Bio') (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by ...